A research study in Colombia to test the acceptability and feasibility of an intervention called DIALOG+, adapted to improve care for people in primary care with poor physical and mental health

Testing the acceptability and feasibility of DIALOG+ in patients with common chronic conditions and poor mental health in primary care in Colombia: a non-randomized study with before and after design

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14018729

Enrollment

Registered

2020-12-01

Start date

2021-01-01

Completion date

Unknown

Last updated

2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) Not Applicable

Interventions

DIALOG+ is a technology-mediated intervention, which involves a structured patient assessment covering satisfaction with eight life domains and three treatment domains (DIALOG scale) and a four-step s

including barriers and facilitators of attending intervention sessions, suggested adaptations and the practical delivery of the intervention. In addition to the research data collection described abo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of =1 common chronic condition such as diabetes, hypertension, COPD, CVD, etc 2. Quality of life score measured on the MANSA =5.5 3. Capacity to provide informed consent 4. Able to speak and understand the local language 5. Attending the outpatient clinic for at least six months 6. Live within a 20 km radius of the clinic 7. Aged 18-65 years old

Exclusion criteria

Exclusion criteria: 1. Unable or unwilling to provide informed consent 2. Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
1. Quality of life measured using the Manchester Short Assessment (MANSA) at baseline and 3 months 2. Depression measured using the Patient Health Questionnaire (PHQ-8) at baseline and 3 months 3. Anxiety measured using Generalised Anxiety Disorder assessment (GAD-7) at baseline and 3 months 4. Objective social functioning measured using objective social outcomes index (SIX) at baseline and 3 months 5. Physical health symptoms measured using The Short Form (36) Health Survey (SF-36) at baseline and 3 months	—

Measure

Time frame

1. Quality of life measured using the Manchester Short Assessment (MANSA) at baseline and 3 months 2. Depression measured using the Patient Health Questionnaire (PHQ-8) at baseline and 3 months 3. Anxiety measured using Generalised Anxiety Disorder assessment (GAD-7) at baseline and 3 months 4. Objective social functioning measured using objective social outcomes index (SIX) at baseline and 3 months 5. Physical health symptoms measured using The Short Form (36) Health Survey (SF-36) at baseline and 3 months

—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Colombia

Contacts

Public ContactFrancois van Loggerenberg

f.vanloggerenberg@qmul.ac.uk+44 (0)207 540 4380 Ext: 2339

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 21, 2026